In addition to pyrazinoic acid and 5-hydroxypyrazinoic acid, a new metabolite of the tuberculostatic agent pyrazinamide, 5-hydroxypyrazinamide has been identified after in vitro incubation of the drug with rat liver preparations. The structure of the new metabolite was elucidated by GLC analysis and, after isolation by TLC, by MS analysis. Formation of the metabolite is mediated by soluble Xanthine oxidase and is an alternative pathway for pyrazinamide detoxification by the liver cell.

In vitro biotransformation of pyrazinamide by rat liver: identification of a new metabolite / D. Pitrè, R. Maffei Facino, M. Carini, A. Carlo. - In: PHARMACOLOGICAL RESEARCH COMMUNICATIONS. - ISSN 0031-6989. - 13:4(1981), pp. 351-362.

In vitro biotransformation of pyrazinamide by rat liver: identification of a new metabolite

R. Maffei Facino
Secondo
;
M. Carini
Penultimo
;
1981

Abstract

In addition to pyrazinoic acid and 5-hydroxypyrazinoic acid, a new metabolite of the tuberculostatic agent pyrazinamide, 5-hydroxypyrazinamide has been identified after in vitro incubation of the drug with rat liver preparations. The structure of the new metabolite was elucidated by GLC analysis and, after isolation by TLC, by MS analysis. Formation of the metabolite is mediated by soluble Xanthine oxidase and is an alternative pathway for pyrazinamide detoxification by the liver cell.
Settore CHIM/08 - Chimica Farmaceutica
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/182941
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 22
social impact